Depolarizing stimuli cause persistent and selective loss of orexin in rat hypothalamic slice culture

Peptides

Volumn 31, Issue 6, 2010, Pages 1131-1138

  Katsuki, Hiroshi ^a   Kurosu, Shinsuke ^b   Michinaga, Shotaro ^a   Hisatsune, Akinori ^a   Isohama, Yoichiro ^a   Izumi, Yasuhiko ^b   Kume, Toshiaki ^b   Akaike, Akinori ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

c Fos; Depolarization; Dynorphin; Hypocretin; Hypothalamus; Melanin concentrating hormone

Indexed keywords

DYNORPHIN A; MELANIN CONCENTRATING HORMONE; MESSENGER RNA; OREXIN; POTASSIUM ION; PREPROOREXIN; PROTEIN C FOS; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; VERATRIDINE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HORMONE RELEASE; HYPOTHALAMUS; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL STIMULATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE;

ANIMALS; DYNORPHINS; HYPOTHALAMIC HORMONES; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANINS; NEUROMUSCULAR DEPOLARIZING AGENTS; NEURONS; NEUROPEPTIDES; PITUITARY HORMONES; POTASSIUM; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RNA, MESSENGER; VERATRIDINE;

RATTUS;

EID: 77952105468     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.006     Document Type: Article

References (25)

1. Brana C., Benham C., and Sundstrom L. A method for characterizing cell death in vitro by combining propidium iodide staining with immunohistochemistry. Brain Res Protoc 10 (2002) 109-114
2. Buonanno A., and Fields R.D. Gene regulation by electrical activity during neural and skeletal muscle development. Curr Opin Neurobiol 9 (1999) 110-120
3. Chou T.C., Lee C.E., Lu J., Elmquist J.K., Hara J., Willie J.T., et al. Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21 (2001) RC168
4. Crocker A., España R.A., Papadopoulou M., Saper C.B., Faraco J., Sakurai T., et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65 (2005) 1184-1188
5. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81 (1999) 163-221
6. Eggermann E., Bayer L., Serafin M., Saint-Mleux B., Bernheim L., Machard D., et al. The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci 23 (2003) 1557-1562
7. Fujimoto S., Katsuki H., Kume T., and Akaike A. Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures. Neurobiol Dis 22 (2006) 130-142
8. Gallo V., Kingsbury A., Balázs R., and Jørgensen O.S. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J Neurosci 7 (1987) 2203-2213
9. Katsuki H., and Akaike A. Excitotoxic degeneration of hypothalamic orexin neurons in slice culture. Neurobiol Dis 15 (2004) 61-69
10. Katsuki H., and Akaike A. Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation. Neuroreport 16 (2005) 1157-1161
11. Kilduff T.S., and Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 23 (2000) 359-365
12. Koob G.F. A role for brain stress systems in addiction. Neuron 59 (2008) 11-34
13. Michinaga S., Hisatsune A., Isohama Y., and Katsuki H. Inhibition of neural activity depletes orexin from rat hypothalamic slice culture. J Neurosci Res 88 (2010) 214-221
14. Moodirousta M., Mainville L., and Jones B.E. Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors. Eur J Neurosci 21 (2005) 2807-2816
15. Nishino S., Ripley B., Overeem S., Lammers G.J., and Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39-40
16. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6 (2000) 991-997
17. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8 (2007) 171-181
18. Salthun-Lassalle B., Hirsch E.C., Wolfart J., Ruberg M., and Michel P.P. Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci 24 (2004) 5922-5930
19. Scammell T.E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 53 (2003) 154-166
20. Sheng H.Z., Fields R.D., and Nelson P.G. Specific regulation of immediate early genes by patterned neuronal activity. J Neurosci Res 35 (1993) 459-467
21. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Sulyani S., Aldrich M., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 (2000) 469-474
22. Ulbricht W. Effects of veratridine on sodium currents and fluxes. Rev Physiol Biochem Pharmacol 133 (1998) 1-54
23. Wang S.Y., and Wang G.K. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell Signal 15 (2003) 151-159
24. Watts A.G., and Sanchez-Watts G. Rapid and preferential activation of c-Fos protein in hypocretin/orexin neurons following the reversal of dehydration-anorexia. J Comp Neurol 502 (2007) 768-782
25. Zupanc G.K. Peptidergic transmission: from morphological correlates to functional implications. Micron 27 (1996) 35-91